Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts


  Free Subscription


1 Am J Clin Pathol
1 Am J Hematol
2 Blood
2 Bone Marrow Transplant
2 Br J Haematol
1 Cancer Lett
1 Clin Infect Dis
1 Exp Hematol
1 J Biol Chem
4 Leuk Res
3 Leukemia
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Clin Pathol

  1. WHEELER FC, Kim AS, Mosse CA, Shaver AC, et al
    Limited Utility of Fluorescence In Situ Hybridization for Recurrent Abnormalities in Acute Myeloid Leukemia at Diagnosis and Follow-up.
    Am J Clin Pathol. 2018 Mar 10. pii: 4925842. doi: 10.1093.
    PubMed     Text format     Abstract available

    Am J Hematol

  2. LI Z, Labopin M, Ciceri F, Blaise D, et al
    Haploidentical transplantation outcomes for secondary acute myeloid leukemia: ALWP of the EBMT study.
    Am J Hematol. 2018 Mar 14. doi: 10.1002/ajh.25087.
    PubMed     Text format     Abstract available


  3. HALLEK M, Cheson BD, Catovsky D, Caligaris-Cappio F, et al
    Guidelines for diagnosis, indications for treatment, response assessment and supportive management of chronic lymphocytic leukemia.
    Blood. 2018 Mar 14. pii: blood-2017-09-806398. doi: 10.1182/blood-2017-09-806398
    PubMed     Text format     Abstract available

  4. YAMATO G, Shiba N, Yoshida K, Hara Y, et al
    RUNX1 mutations in pediatric acute myeloid leukemia are associated with distinct genetic features and an inferior prognosis.
    Blood. 2018 Mar 14. pii: blood-2017-11-814442. doi: 10.1182/blood-2017-11-814442
    PubMed     Text format    

    Bone Marrow Transplant

  5. INOUE Y, Fuji S, Tanosaki R, Inamoto Y, et al
    Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0139.
    PubMed     Text format     Abstract available

  6. MARKEY KA, Gartlan KH, Kuns RD, Lane SW, et al
    Conventional dendritic cells are required for the cross-presentation of leukemia-specific antigen in a model of AML relapse post-BMT.
    Bone Marrow Transplant. 2018 Mar 13. pii: 10.1038/s41409-018-0148.
    PubMed     Text format    

    Br J Haematol

  7. PAN X, Nariai N, Fukuhara N, Saito S, et al
    Monitoring of minimal residual disease in early T-cell precursor acute lymphoblastic leukaemia by next-generation sequencing.
    Br J Haematol. 2017;176:318-321.
    PubMed     Text format    

  8. GIBSON SE, Leeman-Neill RJ, Jain S, Piao W, et al
    Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene.
    Br J Haematol. 2015 Nov 16. doi: 10.1111/bjh.13844.
    PubMed     Text format    

    Cancer Lett

  9. FARAONI I, Aloisio F, De Gabrieli A, Consalvo MI, et al
    The poly(adp-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by nf-kappab activation.
    Cancer Lett. 2018 Mar 8. pii: S0304-3835(18)30197.
    PubMed     Text format     Abstract available

    Clin Infect Dis

  10. YAMANASHI H, Koyamatsu J, Nagayoshi M, Shimizu Y, et al
    Human T-cell Leukemia Virus-1 Infection is Associated with Atherosclerosis as Measured by Carotid Intima-Media Thickness in Japanese Community-Dwelling Older People.
    Clin Infect Dis. 2018 Feb 26. pii: 4909834. doi: 10.1093.
    PubMed     Text format     Abstract available

    Exp Hematol

  11. ORTI G, Sanz J, Garcia-Cadenas I, Sanchez-Ortega I, et al
    Analysis of relapse post transplant in acute leukemia, a comparative on second allogeneic hematopoietic cell transplant and donor lymphocyte infusions.
    Exp Hematol. 2018 Mar 8. pii: S0301-472X(18)30120.
    PubMed     Text format     Abstract available

    J Biol Chem

  12. CHERIAN MA, Olson S, Sundaramoorthi H, Cates K, et al
    An activating mutation of interferon regulatory factor 4 (IRF4) in adult T cell leukemia.
    J Biol Chem. 2018 Mar 14. pii: RA117.000164. doi: 10.1074/jbc.RA117.000164.
    PubMed     Text format     Abstract available

    Leuk Res

    Interpretation of clinical endpoints in trials of acute myeloid leukemia.
    Leuk Res. 2018;68:32-39.
    PubMed     Text format     Abstract available

  14. SEDDON AN, Chaim J, Akin O, Drill E, et al
    Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia.
    Leuk Res. 2018;68:48-50.
    PubMed     Text format     Abstract available

  15. CHOI EJ, Lee JH, Lee JH, Park HS, et al
    Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemia.
    Leuk Res. 2018;68:51-56.
    PubMed     Text format     Abstract available

  16. DAI Q, Liu X, Yang H, Guo S, et al
    No prognostic significance of immunophenotypic changes at the end of remission induction therapy in children with B-lineage acute lymphoblastic leukemia.
    Leuk Res. 2018;68:57-61.
    PubMed     Text format     Abstract available


  17. CRAMER SD, Hixon JA, Andrews C, Porter RJ, et al
    Mutant IL-7Ralpha and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia.
    Leukemia. 2018 Feb 15. pii: 10.1038/s41375-017-0001.
    PubMed     Text format    

  18. HNIZDA A, Fabry M, Moriyama T, Pachl P, et al
    Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation.
    Leukemia. 2018 Feb 25. pii: 10.1038/s41375-018-0073.
    PubMed     Text format     Abstract available

  19. ALI A, Penneroux J, Dal Bello R Jr, Masse A, et al
    Granulomonocytic progenitors are key target cells of azacytidine in higher risk myelodysplastic syndromes and acute myeloid leukemia.
    Leukemia. 2018 Feb 26. pii: 10.1038/s41375-018-0076.
    PubMed     Text format    

    PLoS One

  20. DZNELADZE I, Woolley JF, Rossell C, Han Y, et al
    SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.
    PLoS One. 2018;13:e0191510.
    PubMed     Text format     Abstract available

  21. COULIBALY A, Haas A, Steinmann S, Jakobs A, et al
    The natural anti-tumor compound Celastrol targets a Myb-C/EBPbeta-p300 transcriptional module implicated in myeloid gene expression.
    PLoS One. 2018;13:e0190934.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.